The effect and mechanism of forsinopril on ventricular hypertrophy of SHR and left ventricular pressure overloading rat

被引:0
|
作者
Huang Kai
Dai Guizhu
机构
[1] Huazhong University of Science and Technology,Cardiovascular Disease Institute, Xiehe Hospital, Tongji Medical College
关键词
Forsinopril; left ventricular hypertrophy; TGF-β1 gene;
D O I
10.1007/BF02904778
中图分类号
学科分类号
摘要
The effects and mechanism of long-term angiotensin converting enzyme inhibitor (ACEI) Forsinopril on left ventricular hypertrophy of spontaneous hypertension rat (SHR) and left ventricular pressure overloading rat were studied. The left ventricular index (left ventricle weight/body weight) was used to evaluate left ventricular hypertrophy and the in situ hybridization to investigate the TGF-β1 gene expression in left ventricle. The results showed that Forsinopril significantly decreased the left ventricular index of both SHR and left ventricle pressure overloading rat. Forsinopril reduced the integral photic density of TGF-β1 gene statement from 2.836±0.314 to 1.91±0.217 (P<0.01,n=8) of SHR rat and from 3.071±0.456 to 2.376±0.379 (P<0.01,n=8) of left ventricular pressure overloading rat respectively. It was concluded that Forsinopril could prevent the occurrence of left ventricular hypertrophy and reduce the TGF-β1 gene expression in left ventricle of both SHR and left ventricular pressure overloading rat significantly.
引用
收藏
页码:17 / 20
页数:3
相关论文
共 50 条
  • [2] Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR
    Ke, YS
    Cao, H
    Yang, T
    ACTA PHARMACOLOGICA SINICA, 2000, 21 (11): : 1043 - 1047
  • [3] The Effect of "Unclassified" Blood Pressure Phenotypes on Left Ventricular Hypertrophy
    Kasap-Demir, Belde
    Basaran, Cemaliye
    Demircan, Tuelay
    Erfidan, Gokcen
    Ozdemir-Simsek, Ozgur
    Arslansoyu-Camlar, Secil
    Alaygut, Demet
    Mutlubas, Fatma
    Karadeniz, Cem
    TURKISH ARCHIVES OF PEDIATRICS, 2024, 59 (01): : 43 - 48
  • [4] Left ventricular hypertrophy
    Philip R. Liebson
    Current Treatment Options in Cardiovascular Medicine, 1999, 1 (3) : 219 - 230
  • [5] Sirt1 hyperexpression in SHR heart related to left ventricular hypertrophy
    Li, Ling
    Zhao, Lei
    Yi-Ming, Wuliya
    Yu, Yong-Sheng
    Xia, Chun-Yan
    Duan, Jun-Li
    Su, Ding-Feng
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 87 (01) : 56 - 62
  • [6] The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy
    Kucukler, Nagehan
    Kurt, Ibrahim H.
    Topaloglu, Caner
    Gurbuz, Suleyman
    Yalcin, Fatih
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2012, 13 (03) : 181 - 186
  • [7] The effect of nebivolol on left ventricular hypertrophy in hypertension
    Liu, GS
    Wang, LY
    Van Nueten, L
    Ooms, LA
    Van Nueten, L
    Borgers, M
    Van Nueten, L
    Janssen, PA
    Van Nueten, L
    CARDIOVASCULAR DRUGS AND THERAPY, 1999, 13 (06) : 549 - 551
  • [8] The Effect of Nebivolol on Left Ventricular Hypertrophy in Hypertension
    Guo-Shu Liu
    Lian Yi Wang
    Luc Van Nueten
    Leo AA Ooms
    Marcel Borgers
    Paul AJ Janssen
    Cardiovascular Drugs and Therapy, 1999, 13 : 549 - 551
  • [9] An effect of left ventricular hypertrophy on mild-to-moderate left ventricular diastolic dysfunction
    Kattel, Sharma
    Memon, Salim
    Saito, Keiko
    Narula, Jagat
    Saito, Yuji
    HELLENIC JOURNAL OF CARDIOLOGY, 2016, 57 (02) : 92 - 98
  • [10] RIGHT VENTRICULAR ADAPTATION TO THE LEFT VENTRICULAR HYPERTROPHY
    Escudero, Manuel E.
    Tufare, Ana
    Pinilla, Oscar
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2010, 39 (04): : 282 - 287